Idera Pharmaceuticals, Inc. Reports Financial Results for the Three Months Ended March 31, 2007

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals (AMEX: IDP) today announced financial results for the quarter ended March 31, 2007 and provided an outline of its expanded oncology clinical trials program for its lead candidate, IMO-2055.